Top Markets
Coin of the day
Biotest AG Biotest AG

Biotest AG

BIO
Rangering i aksjer #7311
Biotest AG is a German biopharmaceutical company focused on the global... Biotest AG is a German biopharmaceutical company focused on the global development, manufacturing, and commercialization of biological medications. The firm organizes its activities into the Therapy, Plasma & Services, and Other segments. Its product portfolio addresses critical needs in hematology, clinical immunology, and intensive care medicine. Among its offerings are treatments for hemophilia A (such as Haemoctin and Vihuma) and hemophilia B (like Haemonine), covering both acute care and prevention. Biotest also provides therapies for various viral infections, including cytomegalovirus (Cytotect CP), hepatitis B (Fovepta, Hepatect, Zutectra), and varicella zoster (Varitect). Additionally, its products, such as Intratect and IgG Next Generation, are utilized for primary and secondary immune deficiencies, autoimmune disorders, and certain neurological conditions. The company further supplies solutions to manage circulating blood volume (Albiomin, Biseko), address clotting factor deficiencies (Cofact, Fibrinogen), and combat serious infections like community-acquired pneumonia and COVID-19 (Trimodulin), as well as general bacterial infections (Pentaglobin). Established in 1946 as Biotest Serum-Institut GmbH, the company adopted its current name, Biotest Aktiengesellschaft, in 1986. Headquartered in Dreieich, Germany, Biotest Aktiengesellschaft has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.
Aksjekurs
$47.45
Sist synkronisert: 2026-05-13
Markedsverdi
$1.63B
Endring (1 dag)
2.04%
Endring (1 år)
3.15%
Land
DE
Handel Biotest AG (BIO)

Kategori

Aksjeprishistorikk for Biotest AG (BIO)
Høyeste sluttskurs: $47.86 den 2026-05-01

Laveste sluttskurs: $6.49 den 1998-11-01
Aksjeprishistorikk for Biotest AG fra 1998 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 4.97%
2025 -1.89%
2024 -6.52%
2023 1.79%
2022 -5.71%
2021 41.57%
2020 54.29%
2019 -25.81%
2018 8.86%
2017 57.83%
2016 -6.25%
2015 -48.27%
2014 5.79%
2013 52.48%
2012 28.11%
2011 -13.50%
2010 6.55%
2009 -15.37%
2008 22.41%
2007 46.70%
2006 31.41%
2005 82.28%
2004 76.04%
2003 68.97%
2002 -56.60%
2001 -19.56%
2000 3.02%
1999 -24.95%
1998 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$762.91 7.41%
CH